Frontlight ResearchEarly access
Myasthenia gravis trials in Italy
12 of 32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Where
- Bergamo, Milan, Naples
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07294170 - No phaseTaking peoplePANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
- Where
- Milan
- Age
- 18 years and over
- People
- 40
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07717281 - No phaseTaking peopleA Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
- Where
- Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova, Messina, Milan, Monserrato, Naples, Orbassano, Padova, Pavia, Perugia, Pisa, Rimini, Roma, Salerno, San Giovanni Rotondo, Sassari, Treviso, Verona
- Age
- 18 years and over
- People
- 100
- Run by
- argenx
See details and how to joinNCT07595653 - No phaseNot yet taking people in ItalyThymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis
- Where
- Milan
- Age
- 18 years and over
- People
- 40
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07571525 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Rome
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Milan, Naples
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341 - No phaseTaking peopleA Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Where
- Bergamo, Bologna, Naples, Pisa, Roma
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- argenx
See details and how to joinNCT06298565 - No phaseTaking peopleA Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Where
- Roma
- People
- 279 worldwide
- Run by
- argenx
See details and how to joinNCT06299748 - No phaseTaking peopleEarly Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
- Where
- Bergamo, Bologna, Brescia, Florence, Imperia, Lecco, Messina, Milan, Naples, Novara, Orbassano, Padova, Palermo, Parma, Pavia, Pisa, Roma, Salerno, San Giovanni Rotondo, Sassari, Torino
- Age
- 18 years and over
- People
- 40
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06967480 - No phaseNot yet taking people in ItalyProteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
- Where
- Roma
- Age
- 18 years and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07337395 - No phaseTaking peopleMarkers of Favorable Response to Complement Inhibitors Therapy
- Where
- Roma
- Age
- 18 years and over
- People
- 50
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06455709 - No phaseTaking peopleAnalysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
- Where
- Roma
- Age
- 18 years and over
- People
- 40
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06941584